Stay updated on ED-SCLC Immuno-Therapy Clinical Trial

Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    An updated study site listing appears as Taoyuan, Taiwan, 333, and the Taoyuan District listing is removed; the page also adds Lung cancer as a topic and includes related topics such as MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-05-02T04:30:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page footer now shows an updated system/version label (“Revision: v3.5.3”). Related topic text in the surrounding MedlinePlus/links area was adjusted, without changing the study’s core details.
    Difference
    0.1%
    Check dated 2026-04-24T22:18:13.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Ono Pharmaceutical Co., Ltd. was added as a collaborator; revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:56:12.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added related topics such as Lung cancer and MedlinePlus Genetics to the page.
    Difference
    0.1%
    Check dated 2026-04-10T08:58:50.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Lung cancer, related topics, and MedlinePlus Genetics links were removed from the page.
    Difference
    0.1%
    Check dated 2026-04-03T05:37:17.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Lung cancer and related topics, including MedlinePlus Genetics, were added to the page.
    Difference
    0.1%
    Check dated 2026-03-27T02:14:11.000Z thumbnail image

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.